| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.97M | 37.77M | 0.00 | 0.00 | 19.50M | 17.48M |
| Gross Profit | 8.64M | 6.51M | 0.00 | 3.30M | 3.23M | 2.86M |
| EBITDA | 152.00K | 11.25M | -3.51M | -2.38M | -3.40M | -4.30M |
| Net Income | -4.30M | -5.74M | 2.41M | 10.05M | -3.53M | -4.62M |
Balance Sheet | ||||||
| Total Assets | 105.03M | 99.98M | 16.67M | 20.97M | 10.65M | 14.29M |
| Cash, Cash Equivalents and Short-Term Investments | 1.84M | 1.76M | 16.08M | 14.44M | 3.85M | 7.13M |
| Total Debt | 78.61M | 75.55M | 7.00K | 284.00K | 184.00K | 1.11M |
| Total Liabilities | 93.51M | 88.09M | 1.14M | 7.57M | 7.46M | 7.62M |
| Stockholders Equity | 9.32M | 9.84M | 15.53M | 13.40M | 3.19M | 6.67M |
Cash Flow | ||||||
| Free Cash Flow | -4.20M | -5.22M | 479.00K | 10.66M | -3.11M | -1.64M |
| Operating Cash Flow | -3.40M | -4.05M | 518.00K | 10.66M | -3.00M | -1.58M |
| Investing Cash Flow | -791.00K | -35.15M | 1.51M | -29.00K | -90.00K | 139.00K |
| Financing Cash Flow | 4.21M | 24.88M | -473.00K | 39.00K | -187.00K | 1.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
48 Neutral | $7.64M | -3.28 | ― | ― | 95.23% | 34.97% | |
44 Neutral | $4.04M | -1.40 | -50.26% | ― | -66.59% | 67.63% | |
42 Neutral | $3.67M | -0.04 | ― | ― | -62.46% | -12.90% | |
41 Neutral | $11.19M | -0.06 | -164.27% | ― | 4.59% | -920.35% | |
25 Underperform | $5.01M | >-0.01 | -113.86% | ― | 2482.80% | -169.59% |
On January 19, 2026, Lendway’s Bloomia subsidiaries amended their existing $12.75 million bridge loan tied to the Bloomia acquisition, securing the right to prepay the full amount at a discounted $7.33 million before April 15, 2026 without interest or penalties, in exchange for releasing the former owners from remaining warranty and indemnity liabilities under the sale agreement. The bridge loan, which carries a step-up interest rate schedule through its March 24, 2029 maturity and had accumulated $2.843 million in accrued interest as of December 31, 2025, is expected to be repaid using proceeds from a newly announced rights offering, which aims to raise up to $15.5 million and could immediately reduce overall company debt by up to 40% and potentially by as much as 70% by early summer, while also funding related-party note settlements, strategic investments and a rebranding of the listed entity as Bloomia Holdings, Inc. with a planned Nasdaq ticker change to TULP.
The most recent analyst rating on (LDWY) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Lendway stock, see the LDWY Stock Forecast page.
On November 19, 2025, Lendway, Inc. filed a Certificate of Amendment to increase its authorized common stock shares from 5,714,285 to 10,000,000, following approval by the Board of Directors and stockholders. During the 2025 Annual Meeting of Stockholders, six directors were elected, executive compensation was approved, Boulay PLLP was ratified as the accounting firm, and the amendment for increasing authorized shares was passed.